Instil Bio Inc (TIL)
29.44
-2.10
(-6.66%)
USD |
NASDAQ |
Nov 14, 16:00
29.06
-0.38
(-1.29%)
After-Hours: 20:00
Instil Bio Free Cash Flow (Quarterly): -10.61M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -10.61M |
March 31, 2024 | -14.39M |
December 31, 2023 | -13.44M |
September 30, 2023 | -19.58M |
June 30, 2023 | -26.54M |
March 31, 2023 | -43.13M |
December 31, 2022 | -49.99M |
September 30, 2022 | -66.08M |
June 30, 2022 | -73.40M |
Date | Value |
---|---|
March 31, 2022 | -75.29M |
December 31, 2021 | -61.25M |
September 30, 2021 | -51.14M |
June 30, 2021 | -40.72M |
March 31, 2021 | -26.86M |
December 31, 2020 | -62.09M |
September 30, 2020 | -11.54M |
June 30, 2020 | -3.551M |
March 31, 2020 | -3.25M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-75.29M
Minimum
Mar 2022
-3.25M
Maximum
Mar 2020
-36.27M
Average
-33.79M
Median
Free Cash Flow (Quarterly) Benchmarks
Merck & Co Inc | 8.508B |
Elite Pharmaceuticals Inc | 1.466M |
BioCardia Inc | -1.315M |
Zevra Therapeutics Inc | -19.11M |
NovaBay Pharmaceuticals Inc | -2.063M |